Diagnostic Radiation Exposure in Patients with Inflammatory Bowel Disease

Background. Because of the chronic and relapsing nature of inflammatory bowel disease (IBD), which often requires characterization with CT scan, IBD patients might be exposed to a large amount of radiation. As a cumulative effective dose (CED) ≥ 100 mSv is considered significant for stochastic risks...

Full description

Saved in:
Bibliographic Details
Main Authors: Catherine Langevin, Lysanne Normandeau, Mickael Bouin
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2019/2030735
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849305624126423040
author Catherine Langevin
Lysanne Normandeau
Mickael Bouin
author_facet Catherine Langevin
Lysanne Normandeau
Mickael Bouin
author_sort Catherine Langevin
collection DOAJ
description Background. Because of the chronic and relapsing nature of inflammatory bowel disease (IBD), which often requires characterization with CT scan, IBD patients might be exposed to a large amount of radiation. As a cumulative effective dose (CED) ≥ 100 mSv is considered significant for stochastic risks of cancer, it is important to monitor and control the radiation exposure of the IBD patients. In the present work, we aimed to quantify the mean CED in IBD patients to assess any harmful effects of radiation. Methods. This study includes 200 IBD patients, identified retrospectively, from the outpatient clinics of the Centre Hospitalier de l’Université de Montréal between January 1, 2010, and February 15, 2017, from the gastroenterologists’ patients lists. The number and type of each radiology test performed were listed for each patient during the study period and the CED was calculated using our institution’s dose index when available and standardized tables. Results. Among the 200 IBD patients, 157 patients had Crohn’s disease (CD), 41 had ulcerative colitis (UC), and 2 had indeterminate colitis. The mean CED for IBD patients was 23.1 ± 45.2 mSv during a mean follow-up duration of 4.3 years. CED was higher among patients with CD than with UC (27.5 ± 49.5 versus 6.8 ± 14.8 mSv; p<0.01). Six patients were exposed to a high CED (>100 mSv) and all had CD. Conclusion. While potentially harmful levels of radiation exposure are of concern in only a small number of patients, strategies to limit such exposure are encouraged when clinically appropriate.
format Article
id doaj-art-067dc63cdc6d4cf3b464a00ecd8a58af
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-067dc63cdc6d4cf3b464a00ecd8a58af2025-08-20T03:55:23ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972019-01-01201910.1155/2019/20307352030735Diagnostic Radiation Exposure in Patients with Inflammatory Bowel DiseaseCatherine Langevin0Lysanne Normandeau1Mickael Bouin2Gastroenterology Division, Centre Hospitalier de l’Université de Montréal, Quebec, CanadaHealth Physicist, Centre Hospitalier de l’Université de Montréal, CanadaGastroenterology Division, Centre Hospitalier de l’Université de Montréal, Quebec, CanadaBackground. Because of the chronic and relapsing nature of inflammatory bowel disease (IBD), which often requires characterization with CT scan, IBD patients might be exposed to a large amount of radiation. As a cumulative effective dose (CED) ≥ 100 mSv is considered significant for stochastic risks of cancer, it is important to monitor and control the radiation exposure of the IBD patients. In the present work, we aimed to quantify the mean CED in IBD patients to assess any harmful effects of radiation. Methods. This study includes 200 IBD patients, identified retrospectively, from the outpatient clinics of the Centre Hospitalier de l’Université de Montréal between January 1, 2010, and February 15, 2017, from the gastroenterologists’ patients lists. The number and type of each radiology test performed were listed for each patient during the study period and the CED was calculated using our institution’s dose index when available and standardized tables. Results. Among the 200 IBD patients, 157 patients had Crohn’s disease (CD), 41 had ulcerative colitis (UC), and 2 had indeterminate colitis. The mean CED for IBD patients was 23.1 ± 45.2 mSv during a mean follow-up duration of 4.3 years. CED was higher among patients with CD than with UC (27.5 ± 49.5 versus 6.8 ± 14.8 mSv; p<0.01). Six patients were exposed to a high CED (>100 mSv) and all had CD. Conclusion. While potentially harmful levels of radiation exposure are of concern in only a small number of patients, strategies to limit such exposure are encouraged when clinically appropriate.http://dx.doi.org/10.1155/2019/2030735
spellingShingle Catherine Langevin
Lysanne Normandeau
Mickael Bouin
Diagnostic Radiation Exposure in Patients with Inflammatory Bowel Disease
Canadian Journal of Gastroenterology and Hepatology
title Diagnostic Radiation Exposure in Patients with Inflammatory Bowel Disease
title_full Diagnostic Radiation Exposure in Patients with Inflammatory Bowel Disease
title_fullStr Diagnostic Radiation Exposure in Patients with Inflammatory Bowel Disease
title_full_unstemmed Diagnostic Radiation Exposure in Patients with Inflammatory Bowel Disease
title_short Diagnostic Radiation Exposure in Patients with Inflammatory Bowel Disease
title_sort diagnostic radiation exposure in patients with inflammatory bowel disease
url http://dx.doi.org/10.1155/2019/2030735
work_keys_str_mv AT catherinelangevin diagnosticradiationexposureinpatientswithinflammatoryboweldisease
AT lysannenormandeau diagnosticradiationexposureinpatientswithinflammatoryboweldisease
AT mickaelbouin diagnosticradiationexposureinpatientswithinflammatoryboweldisease